Chronic Kidney Disease in Pregnant Mothers affects Maternal and Fetal Disposition of Mercury

Publication date: Available online 19 February 2020Source: Reproductive ToxicologyAuthor(s): Renee F. Moss, Hannah S. George, Sanya Nijhara, Sarah E. Orr, Lucy Joshee, Jennifer L. Barkin, Christy C. BridgesAbstractChronic kidney disease (CKD) affects over 15% of the adults in the United States. Pregnant women with CKD present an additional challenge in that they are at increased risk for adverse events such as preterm birth. Exposure to environmental toxicants, such as methylmercury, may exacerbate maternal disease and increase the risk of adverse fetal outcomes. We hypothesized that fetuses of mothers with CKD are more susceptible to accumulation of methylmercury than fetuses of healthy mothers. The current data show that when mothers are in a state of renal insufficiency, uptake of mercury in fetal kidneys is enhanced significantly. Accumulation of Hg in fetal kidneys may be related to the flow of amniotic fluid, maternal handling of Hg, and/or underdeveloped mechanisms for cellular export and urinary excretion. The results of this study indicate that renal insufficiency in mothers leads to significant alterations in the way toxicants such as mercury are handled by maternal and fetal organs.
Source: Reproductive Toxicology - Category: Toxicology Source Type: research